CytomX Therapeutics, Inc. Increase (Decrease) in Accounts Receivable
CytomX Therapeutics, Inc. (CTMX) reported Increase (Decrease) in Accounts Receivable of $35.48 million for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInAccountsReceivable · last filed 2026-08-06
- CytomX Therapeutics, Inc. increase (decrease) in accounts receivable for the quarter ending 2026-06-30 was $36.85M.
- CytomX Therapeutics, Inc. increase (decrease) in accounts receivable for the quarter ending 2026-03-31 was -$1.37M.
- CytomX Therapeutics, Inc. increase (decrease) in accounts receivable for the quarter ending 2025-12-31 was $384.00K.
- CytomX Therapeutics, Inc. increase (decrease) in accounts receivable for the quarter ending 2025-09-30 was -$240.00K, a 141.59% decline year-over-year.
- CytomX Therapeutics, Inc. increase (decrease) in accounts receivable for fiscal 2025 was -$1.09M.
- CytomX Therapeutics, Inc. increase (decrease) in accounts receivable for fiscal 2024 was -$329.00K.
- CytomX Therapeutics, Inc. increase (decrease) in accounts receivable for fiscal 2023 was -$32.55M, a 192.49% decline from fiscal 2022.
- CytomX Therapeutics, Inc. increase (decrease) in accounts receivable for fiscal 2022 was $35.20M.
| Period end | Increase (Decrease) in Accounts Receivable 3 month | Increase (Decrease) in Accounts Receivable 6 month | Increase (Decrease) in Accounts Receivable 9 month | Increase (Decrease) in Accounts Receivable 9 month as first filed | Increase (Decrease) in Accounts Receivable 12 month |
|---|---|---|---|---|---|
| 2026-06-30 | $36.85M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-06 | $35.48M 10-Q · filed 2026-08-06 | $35.87M derived: sum of 3 quarters · filed 2026-08-06 | $35.63M derived: sum of 4 quarters · filed 2026-08-06 | |
| 2026-03-31 | -$1.37M 10-Q · filed 2026-05-07 | -$983.00K derived: sum of 2 quarters · filed 2026-05-07 | -$1.22M derived: sum of 3 quarters · filed 2026-05-07 | -$1.31M derived: sum of 4 quarters · filed 2026-08-06 | |
| 2025-12-31 | $384.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-16 | $144.00K derived: sum of 2 quarters · filed 2026-03-16 | $57.00K derived: sum of 3 quarters · filed 2026-08-06 | -$1.09M 10-K · filed 2026-03-16 | |
| 2025-09-30 | -$240.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-06 | -$327.00K derived: sum of 2 quarters · filed 2026-08-06 | -$1.47M 10-Q · filed 2025-11-06 | -$1.72M derived: sum of 4 quarters · filed 2026-08-06 | |
| 2025-06-30 | -$87.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-06 | -$1.23M 10-Q · filed 2026-08-06 | -$1.48M derived: sum of 3 quarters · filed 2026-08-06 | -$906.00K derived: sum of 4 quarters · filed 2026-08-06 | |
| 2025-03-31 | -$1.15M 10-Q · filed 2026-05-07 | -$1.40M derived: sum of 2 quarters · filed 2026-05-07 | -$819.00K derived: sum of 3 quarters · filed 2026-05-07 | -$11.22M derived: sum of 4 quarters · filed 2026-05-07 | |
| 2024-12-31 | -$249.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-16 | $328.00K derived: sum of 2 quarters · filed 2026-03-16 | -$10.07M derived: sum of 3 quarters · filed 2026-03-16 | -$329.00K 10-K · filed 2026-03-16 | |
| 2024-09-30 | $577.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-06 | -$9.82M derived: sum of 2 quarters · filed 2025-11-06 | -$80.00K 10-Q · filed 2025-11-06 | $933.00K derived: sum of 4 quarters · filed 2025-11-06 | |
| 2024-06-30 | -$10.40M derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-07 | -$657.00K 10-Q · filed 2025-08-07 | $356.00K derived: sum of 3 quarters · filed 2025-08-07 | $872.00K derived: sum of 4 quarters · filed 2025-08-07 | |
| 2024-03-31 | $9.74M 10-Q · filed 2025-05-12 | $10.76M derived: sum of 2 quarters · filed 2025-05-12 | $11.27M derived: sum of 3 quarters · filed 2025-05-12 | $12.09M derived: sum of 4 quarters · filed 2025-05-12 | |
| 2023-12-31 | $1.01M derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-06 | $1.53M derived: sum of 2 quarters · filed 2025-03-06 | $2.34M derived: sum of 3 quarters · filed 2025-03-06 | -$32.55M 10-K · filed 2025-03-06 | |
| 2023-09-30 | $516.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-07 | $1.33M derived: sum of 2 quarters · filed 2024-11-07 | -$33.57M 10-Q · filed 2024-11-07 | $643.00K derived: sum of 4 quarters · filed 2024-11-07 | |
| 2023-06-30 | $813.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-08 | -$34.08M 10-Q · filed 2024-08-08 | $127.00K derived: sum of 3 quarters · filed 2024-08-08 | $823.00K derived: sum of 4 quarters · filed 2024-08-08 | |
| 2023-03-31 | -$34.90M 10-Q · filed 2024-05-08 | -$686.00K derived: sum of 2 quarters · filed 2024-05-08 | $10.00K derived: sum of 3 quarters · filed 2024-05-08 | $68.00K derived: sum of 4 quarters · filed 2024-05-08 | |
| 2022-12-31 | $34.21M derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-11 | $34.91M derived: sum of 2 quarters · filed 2024-03-11 | $34.96M derived: sum of 3 quarters · filed 2024-03-11 | $35.20M 10-K · filed 2024-03-11 | |
| 2022-09-30 | $696.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-07 | $754.00K derived: sum of 2 quarters · filed 2023-11-07 | $986.00K 10-Q · filed 2023-11-07 | $889.00K derived: sum of 4 quarters · filed 2023-11-07 | |
| 2022-06-30 | $58.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-08 | $290.00K 10-Q · filed 2023-08-08 | $193.00K derived: sum of 3 quarters · filed 2023-08-08 | $149.00K derived: sum of 4 quarters · filed 2023-08-08 | |
| 2022-03-31 | $232.00K 10-Q · filed 2023-05-09 | $135.00K derived: sum of 2 quarters · filed 2023-05-09 | $91.00K derived: sum of 3 quarters · filed 2023-05-09 | $266.00K derived: sum of 4 quarters · filed 2023-05-09 | |
| 2021-12-31 | -$97.00K derived: 10-K/A 12 month − 10-Q 9 month · filed 2023-03-27 | -$141.00K derived: sum of 2 quarters · filed 2023-03-27 | $34.00K derived: sum of 3 quarters · filed 2023-03-27 | -$8.00K 10-K/A · filed 2023-03-27 | |
| 2021-09-30 | -$44.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-08 | $131.00K derived: sum of 2 quarters · filed 2022-11-08 | $89.00K 10-Q · filed 2022-11-08 | $344.00K derived: sum of 4 quarters · filed 2023-03-27 | |
| 2021-06-30 | $175.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-04 | $133.00K 10-Q · filed 2022-08-04 | $388.00K derived: sum of 3 quarters · filed 2023-03-27 | $725.00K derived: sum of 4 quarters · filed 2023-03-27 | |
| 2021-03-31 | -$42.00K 10-Q · filed 2022-05-05 | $213.00K derived: sum of 2 quarters · filed 2023-03-27 | $550.00K derived: sum of 3 quarters · filed 2023-03-27 | -$129.25M derived: sum of 4 quarters · filed 2023-03-27 | |
| 2020-12-31 | $255.00K derived: 10-K/A 12 month − 10-Q 9 month · filed 2023-03-27 | $592.00K derived: sum of 2 quarters · filed 2023-03-27 | -$129.21M derived: sum of 3 quarters · filed 2023-03-27 | $785.00K 10-K/A · filed 2023-03-27 | |
| 2020-09-30 | $337.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-04 | -$129.47M derived: sum of 2 quarters · filed 2021-11-04 | $530.00K 10-Q · filed 2021-11-04 | $536.00K derived: sum of 4 quarters · filed 2023-03-27 | |
| 2020-06-30 | -$129.80M derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-05 | $193.00K 10-Q · filed 2021-08-05 | $199.00K derived: sum of 3 quarters · filed 2023-03-27 | -$9.80M derived: sum of 4 quarters · filed 2023-03-27 | |
| 2020-03-31 | $130.00M 10-Q · filed 2021-05-06 | $130.00M derived: sum of 2 quarters · filed 2023-03-27 | $120.01M derived: sum of 3 quarters · filed 2023-03-27 | $129.97M derived: sum of 4 quarters · filed 2023-03-27 | |
| 2019-12-31 | $6.00K derived: 10-K/A 12 month − 10-Q 9 month · filed 2023-03-27 | -$9.99M derived: sum of 2 quarters · filed 2023-03-27 | -$31.00K derived: sum of 3 quarters · filed 2023-03-27 | -$84.00K 10-K/A · filed 2023-03-27 | |
| 2019-09-30 | -$10.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-05 | -$37.00K derived: sum of 2 quarters · filed 2020-11-05 | -$90.00K 10-Q · filed 2020-11-05 | -$49.00K derived: sum of 4 quarters · filed 2021-02-24 | |
| 2019-06-30 | $9.96M derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-06 | $9.91M 10-Q · filed 2020-08-06 | $9.95M derived: sum of 3 quarters · filed 2021-02-24 | -$15.13M derived: sum of 4 quarters · filed 2021-02-24 | |
| 2019-03-31 | -$53.00K 10-Q · filed 2020-05-07 | -$12.00K derived: sum of 2 quarters · filed 2021-02-24 | -$25.09M derived: sum of 3 quarters · filed 2021-02-24 | -$37.00K derived: sum of 4 quarters · filed 2021-02-24 | |
| 2018-12-31 | $41.00K derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-24 | -$25.04M derived: sum of 2 quarters · filed 2021-02-24 | $16.00K derived: sum of 3 quarters · filed 2021-02-24 | -$10.04M 10-K · filed 2021-02-24 | |
| 2018-09-30 | -$25.08M derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-07 | -$25.00K derived: sum of 2 quarters · filed 2019-11-07 | -$10.08M 10-Q · filed 2019-11-07 | -$127.00K derived: sum of 4 quarters · filed 2020-02-27 | |
| 2018-06-30 | $25.06M derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-07 | $15.00M 10-Q · filed 2019-08-07 | $24.95M derived: sum of 3 quarters · filed 2020-02-27 | $24.98M derived: sum of 4 quarters · filed 2020-02-27 | |
| 2018-03-31 | -$10.06M 10-Q · filed 2019-05-09 | -$102.00K derived: sum of 2 quarters · filed 2020-02-27 | -$77.00K derived: sum of 3 quarters · filed 2020-02-27 | -$132.00K derived: sum of 4 quarters · filed 2020-02-27 | |
| 2017-12-31 | $9.96M derived: 10-K 12 month − 10-Q 9 month · filed 2020-02-27 | $9.98M derived: sum of 2 quarters · filed 2020-02-27 | $9.93M derived: sum of 3 quarters · filed 2020-02-27 | $7.98M 10-K · filed 2020-02-27 | |
| 2017-09-30 | $25.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-06 | -$30.00K derived: sum of 2 quarters · filed 2018-11-06 | -$1.98M 10-Q · filed 2018-11-06 | -$57.00K derived: sum of 4 quarters · filed 2019-02-27 | |
| 2017-06-30 | -$55.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-08 | -$2.00M 10-Q · filed 2018-08-08 | -$82.00K derived: sum of 3 quarters · filed 2019-02-27 | -$127.00K derived: sum of 4 quarters · filed 2019-02-27 | |
| 2017-03-31 | -$1.95M 10-Q · filed 2018-05-09 | -$27.00K derived: sum of 2 quarters · filed 2019-02-27 | -$72.00K derived: sum of 3 quarters · filed 2019-02-27 | -$103.00K derived: sum of 4 quarters · filed 2019-02-27 | |
| 2016-12-31 | $1.92M derived: 10-K 12 month − 10-Q 9 month · filed 2019-02-27 | $1.87M derived: sum of 2 quarters · filed 2019-02-27 | $1.84M derived: sum of 3 quarters · filed 2019-02-27 | $1.79M 10-K · filed 2019-02-27 | |
| 2016-09-30 | -$45.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-07 | -$76.00K derived: sum of 2 quarters · filed 2017-11-07 | -$132.00K 10-Q · filed 2017-11-07 | -$1.34M derived: sum of 4 quarters · filed 2018-03-07 | |
| 2016-06-30 | -$31.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-07 | -$87.00K 10-Q · filed 2017-08-07 | -$1.29M derived: sum of 3 quarters · filed 2018-03-07 | -$1.43M derived: sum of 4 quarters · filed 2018-03-07 | |
| 2016-03-31 | -$56.00K 10-Q · filed 2017-05-05 | -$1.26M derived: sum of 2 quarters · filed 2018-03-07 | -$1.40M derived: sum of 3 quarters · filed 2018-03-07 | -$1.19M derived: sum of 4 quarters · filed 2018-03-07 | |
| 2015-12-31 | -$1.20M derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-07 | -$1.34M derived: sum of 2 quarters · filed 2018-03-07 | -$1.13M derived: sum of 3 quarters · filed 2018-03-07 | -$1.13M 10-K · filed 2018-03-07 | |
| 2015-09-30 | -$141.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-03 | $75.00K derived: sum of 2 quarters · filed 2016-11-03 | $73.00K 10-Q · filed 2016-11-03 | -$1.47M 10-Q · filed 2015-11-23 | $1.39M derived: sum of 4 quarters · filed 2017-03-02 |
| 2015-06-30 | $216.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2016-08-03 | $214.00K 10-Q · filed 2016-08-03 | $1.53M derived: sum of 3 quarters · filed 2017-03-02 | ||
| 2015-03-31 | -$2.00K 10-Q · filed 2016-05-06 | $1.32M derived: sum of 2 quarters · filed 2017-03-02 | |||
| 2014-12-31 | $1.32M derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-02 | $1.64M 10-K · filed 2017-03-02 | |||
| 2014-09-30 | $317.00K 10-Q · filed 2015-11-23 | ||||
| 2013-12-31 | $237.00K 10-K · filed 2016-03-07 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Monopar Therapeutics (MNPR) | United States | $0.598B | -34.82 |
| Altimmune, Inc. (ALT) | United States | $0.593B | -6.43 |
| CorMedix Inc. (CRMD) | United States | $0.605B | 3.25 |
| Aquestive Therapeutics, Inc. (AQST) | United States | $0.606B | -6.67 |
| IMPACT BIOMEDICAL INC. (IBO) | United States | $0.611B | 66.47 |
| Phathom Pharmaceuticals, Inc. (PHAT) | United States | $0.572B | -8.76 |
| Neurogene Inc. (NGNE) | $0.625B | -4.46 | |
| Shattuck Labs, Inc. (STTK) | United States | $0.634B | -13.30 |
| BlossomHill Therapeutics, Inc. (BLSM) | United States | $0.647B | |
| Indaptus Therapeutics, Inc. (INDP) | United States | $0.537B |